Method for producing culture supernatant fluid
The method addresses the low yield of culture supernatant by adhering mesenchymal stem cells to a carrier and using a serum-free medium, resulting in a high-concentration supernatant production through optimized culture and filtration processes.
Patent Information
- Application Number
- JP2023086187
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- Filing Date
- 2023-05-25
- Publication Date
- 2024-12-05
- Estimated Expiration
- 2043-05-25
AI Technical Summary
Existing methods for producing culture supernatant from mesenchymal stem cells result in a small amount of supernatant with low concentrations of active ingredients.
A method involving the use of a culture medium containing a carrier and serum to adhere mesenchymal stem cells, followed by a series of steps including washing and culturing with serum-free medium to collect a high-concentration culture supernatant, utilizing a filter with specific mesh sizes and repeating the process to enhance yield.
The method enables the continuous production of a large amount of culture supernatant with high concentrations of active ingredients, such as cytokines and exosomes, by optimizing the culture conditions and filtration process.
Smart Images

Figure 2024169018000001_ABST
Abstract
Description
[Technical field]
[0001] The present invention relates to a method for producing a culture supernatant of stem cells. [Background technology]
[0002] In medical treatments using mesenchymal stem cells, it is known that not only do the stem cells themselves bring about therapeutic effects, but also various physiologically active substances secreted by stem cells, such as cytokines and exosomes, contribute greatly to the therapeutic effects. When mesenchymal stem cells are artificially cultured, these cytokines and other substances are released from the cells into the culture medium, so the culture medium from which the mesenchymal stem cells have been removed can be collected as culture supernatant and effectively utilized.
[0003] Patent Document 1 discloses a method for producing a culture supernatant, which includes a step of supplying a culture solution to mesenchymal stem cells seeded on the inner surface of a permeable membrane hollow fiber, a step of contacting the mesenchymal stem cells with the culture solution to culture the mesenchymal stem cells, and a step of recovering the culture solution containing components secreted by the mesenchymal stem cells. The invention of Patent Document 1 makes it possible to easily produce a culture supernatant. [Prior art documents] [Patent documents]
[0004] [Patent Document 1] Patent No. 6958350 Summary of the Invention [Problem to be solved by the invention]
[0005] However, the invention of Patent Document 1 has a problem in that the amount of culture supernatant produced is small. Therefore, an object of the present invention is to provide a method for producing a culture supernatant containing an active ingredient at a high concentration in large quantities using mesenchymal stem cells. [Means for solving the problem]
[0006] The present embodiment is a method for producing a culture supernatant obtained by removing mesenchymal stem cells from a culture solution in which mesenchymal stem cells have been cultured. The production method includes the steps of (a) supplying a culture solution containing a carrier, mesenchymal stem cells, and serum (hereinafter, FBS-DMEM) to a culture vessel, (b) adhering the mesenchymal stem cells to the carrier, (c) culturing the mesenchymal stem cells using FBS-DMEM, (d) leaving the mesenchymal stem cells attached to the carrier in the filter and removing the FBS-DMEM, (e) washing the culture vessel, the mesenchymal stem cells attached to the carrier, and the filter, (f) supplying a serum-free culture solution for the supernatant (hereinafter, CM-DMEM) to the culture vessel, (g) culturing the mesenchymal stem cells using CM-DMEM, and (h) leaving the mesenchymal stem cells attached to the carrier in the filter and recovering the CM-DMEM.
[0007] Step (b) may include a first period during which the FBS-DMEM is stirred so that the carriers are suspended in the FBS-DMEM, and a second period during which stirring is stopped. In addition, in step (c), the FBS-DMEM may be stirred so that the carriers are suspended in the FBS-DMEM. In addition, in the step (g), the CM-DMEM may be stirred so that the carriers are suspended in the CM-DMEM.
[0008] The mesh size of the filter is preferably between 70 mesh and 400 mesh. It is preferred that steps (a) to (e) are followed by successive repetition of steps (f) to (h). Additionally, steps (f) to (h) may be repeated two to four times in succession.
[0009] When at least one of cytokines and exosomes is less than a predetermined value in the collected CM-DMEM, steps (c) and (e) are carried out only once; When at least one of cytokines and exosomes is greater than a predetermined value in the recovered CM-DMEM, steps (f) to (h) may be repeated continuously.
[0010] It is preferable that the mesenchymal stem cells are immortalized stem cells, and it is further preferable that the immortalized stem cells are deciduous dental pulp stem cells.
[0011] This embodiment is a method for producing a culture supernatant obtained by removing mesenchymal stem cells from a culture solution in which mesenchymal stem cells have been cultured. The method for producing the culture supernatant includes the steps of (p) culturing mesenchymal stem cells attached to a carrier in a culture tank using a culture solution containing serum (hereinafter, FBS-DMEM), leaving the mesenchymal stem cells attached to the carrier in a filter placed in the culture tank, and removing the FBS-DMEM, (q) after the step (p), washing the culture tank, the mesenchymal stem cells attached to the carrier, and the filter, and (r) after the step (q), supplying a culture solution for the supernatant that does not contain serum (hereinafter, CM-DMEM) to the culture tank, culturing the mesenchymal stem cells using CM-DMEM, leaving the mesenchymal stem cells attached to the carrier in the filter, and recovering the CM-DMEM.
[0012] Steps (p) and (q) may be performed once, and then step (r) may be repeated two to four times in succession, and again steps (p) and (q) may be performed once, and then step (r) may be repeated two to four times in succession.
[0013] The volume of the culture vessel is preferably 5 L to 20 L, and the mesh size of the filter is preferably 70 mesh to 400 mesh. In addition, the mesenchymal stem cells are preferably immortalized stem cells. Effect of the Invention
[0014] According to the method for producing a culture supernatant of the present invention, a large amount of culture supernatant containing an active ingredient at a high concentration can be continuously provided. [Brief description of the drawings]
[0015] [Figure 1] FIG. 2 is a schematic cross-sectional view showing an example of the culture vessel 100 in a state where the filter 30 is not attached. [Diagram 2]1A is a perspective view of a filter 30, and FIG. 1B is a perspective view of a carrier 40. FIG. [Diagram 3] 1 is a flow chart showing an example of a method for producing a culture supernatant. [Figure 4] 1A is a conceptual diagram showing a state in which the culture vessel 100 is filled with culture medium, and FIG. 1B is a conceptual diagram showing a state in which most of the culture medium has been discharged from the culture vessel 100. FIG. BEST MODE FOR CARRYING OUT THEINVENTION
[0016] <Stem cells to be cultured> The stem cells of this embodiment are not particularly limited, but bone marrow mesenchymal stem cells or adipose tissue-derived mesenchymal stem cells are suitable. The animal species is also not particularly limited, and any animal derived from humans, mice, rats, etc. can be used. The type of cells is also not particularly limited, and may be, for example, fibroblasts, endothelial cells, epithelial cells, nerve cells, stem cells, leukocytes, bone cells, muscle cells, adipocytes, etc., and preferably fibroblasts or endothelial cells. More preferred stem cells are human-derived dental pulp stem cells, and in particular, deciduous tooth dental pulp stem cells.
[0017] <Immortalization of mesenchymal stem cells> A method for immortalizing mesenchymal stem cells is disclosed, for example, in U.S. Patent No. 10494606B2. This disclosed method makes it possible to immortalize mesenchymal stem cells by introducing four types of genes, hTERT, bmi-1, E6, and E7, into primary cultured cells obtained by initial culture of mesenchymal stem cells. Another method for immortalizing mesenchymal stem cells is disclosed in U.S. Patent No. 6,146,888. This disclosed method allows for the introduction of the SV40 gene using a viral vector to immortalize mesenchymal stem cells. Another method for immortalizing mesenchymal stem cells includes the introduction of the telomerase reverse transcription enzyme (TERT) gene into mesenchymal stem cells, which also allows for the immortalization of mesenchymal stem cells.
[0018] <Mesenchymal stem cell culture supernatant> In this specification, the culture supernatant is obtained by culturing mesenchymal stem cells and removing the mesenchymal stem cells. In order to improve safety, the culture supernatant is preferably free of animal serum. The culture supernatant can also be free of animal serum by dialysis, solvent replacement, etc.
[0019] The culture supernatant may be frozen or lyophilized, or the lyophilized culture supernatant may be dissolved in a suitable solvent. Good storage stability can be obtained by lyophilization. As a method for lyophilizing the cell culture supernatant, a method commonly used for lyophilization of a liquid containing a protein can be applied.
[0020] The mesenchymal stem cell culture supernatant of this embodiment is preferably a culture supernatant of deciduous dental pulp stem cells, which have high proliferation ability and contain a large amount of cytokines, exosomes, and the like.
[0021] <Culture medium and its preparation> The culture medium used in the method for producing a culture supernatant of the present embodiment is not particularly limited, and may be, for example, DMEM, αMEM, IMDM, Ham's F-12, RPMI-1640, or a mixture thereof as a basal culture medium to which serum such as fetal bovine serum (FBS) or serum substitutes such as KSR (KnockOut™ Serum Replacement), glucose, amino acids, vitamins, antibiotics, etc. are appropriately added.
[0022] In this embodiment, it is preferable to prepare two types of culture medium: a serum-containing culture medium (hereinafter referred to as FBS-DMEM) and a serum-free culture medium for collecting a supernatant (hereinafter referred to as CM-DMEM). FBS-DMEM preferably contains DMEM, 5-20% volume of FBS, and antibiotics. CM-DMEM preferably contains DMEM and antibiotics, etc., and contains little or no serum, in order to obtain a supernatant.
[0023] <Culture tank and culture device> Fig. 1 is a schematic cross-sectional view showing an example of a culture vessel 100 used in this embodiment. Fig. 1 is a view showing a state before a filter 30, which will be described later, is attached.
[0024] The culture vessel 100 has a culture tank 10 with a capacity of 5 l (liters) to 20 l (liters). The culture tank 10 is a member that holds a culture solution inside, and its shape, capacity, and material are appropriately selected according to the purpose of the culture. In this embodiment, the culture tank 10 has a circular bottom and a cylindrical side. The material of the culture tank 10 is not particularly limited, but in this embodiment, the culture tank 10 is preferably made of glass, polycarbonate material, stainless steel, etc., and is preferably made of a transparent material so that the culture state or the stirring state can be visually confirmed. A heater 25 that adjusts the temperature inside the culture tank 10 is wrapped around the lower part of the culture tank 10.
[0025] The culture vessel 100 has a top plate 22. The top plate 22 is a member that covers the upper opening of the culture tank 10, and a plurality of O-rings OR are arranged between the top plate 22 and the culture tank 10 to increase airtightness. The top plate 22 can be made of, for example, polycarbonate or stainless steel. A plurality of openings are formed in the top plate 22, allowing various parts to be attached. In this embodiment, the top plate 22 is equipped with a stirring shaft 13, various sensors 18, a gas supply tube 19, a culture solution discharge nozzle 24, a culture solution supply nozzle (not shown), a gas discharge tube (not shown), and the like.
[0026] A stainless steel stirring paddle 12 is attached to the tip of a stainless steel stirring shaft 13, and a rotary motor 16 is attached to the rear end of the stirring shaft 13. The stirring shaft 13 is rotatably held by a bearing 15. For example, the stirring shaft 13 can be rotated at 5-100 rpm by the rotary motor 16 to stir the culture solution. Instead of providing the stirring paddle 12, rotary motor 16, and stirring shaft 13 in the culture vessel 100, a stirrer (magnetic bar) covered with Teflon (registered trademark) may be placed in the culture tank 10, and the stirrer may be rotated by a magnetic stirrer (agitator) to stir the culture solution.
[0027] The various sensors 18 are attached to the openings of the top plate 22, and measure the oxygen concentration, carbon dioxide concentration, pH, temperature, and the like in the culture solution. The gas supply tube 19 is attached to the openings of the top plate 22, and supplies gases such as oxygen into the culture solution. The gas supply tube 19 is made of, for example, a chemical-resistant material such as fluororesin, and supplies gas from a porous through-hole. A gas exhaust tube (not shown) is also attached to the openings of the top plate 22, and exhausts unnecessary gases such as carbon dioxide. The culture solution supply nozzle (not shown) is attached to the openings of the top plate 22, and supplies the culture solution to the culture tank 10. The culture solution exhaust nozzle 24 is attached to the openings of the top plate 22, and is made of stainless steel, and exhausts the culture solution or the supernatant from the culture tank 10. Note that instead of the openings of the top plate 22, an opening may be provided in the culture tank 10, and the various sensors 18 or the culture solution exhaust nozzle 24 may be attached thereto.
[0028] In addition, a filter holding frame 28 is attached to the top plate 22 or the culture tank 10. The filter holding frame 28 is provided to hold a filter 30 (described later) in a predetermined shape, for example, a cylindrical shape. The filter holding frame 28 is manufactured by combining wires, for example, stainless steel, vertically and horizontally to form a cylindrical shape.
[0029] A control unit (not shown) supplies the culture solution to the culture tank 10 through a culture solution supply nozzle (not shown) and stirs the culture solution with a stirring paddle 12 according to a control program. Based on measurement results from various sensors 18, a gas supply tube 19 supplies oxygen from the gas supply tube 19, exhausts carbon dioxide and the like through a gas exhaust tube (not shown), and raises the temperature of the culture solution with a heater 25. The control program also exhausts the culture solution from a culture solution exhaust nozzle 24 to the outside of the culture tank 10 at a scheduled time. The control program of this embodiment can automate the supply of culture solution, management of the temperature, pH, oxygen concentration, etc. of the culture solution, collection of the culture solution, and cleaning of the inside of the culture tank.
[0030] <filter> FIG. 2(A) is a perspective view showing an example of the filter 30 used in this embodiment. The filter 30 has an overall cylindrical shape, and has a cylindrical portion 32 and a bottom portion 33 formed at the lower portion of the cylindrical portion 32, and the bottom portion 33 is in the shape of a circular bowl. An opening 31 is formed at the upper portion of the cylindrical portion 32. Also, a mounting string 35 for mounting the filter 30 to the filter holding frame 28 or the top plate 22 is provided around the opening 31. The size of the filter 30 depends on the size of the culture tank 10, but for example, the length LL is 150 mm to 500 mm, and the diameter ΦDM is Φ100 mm to 300 mm. The filter 30 is preferably a filter made of polypropylene, polyester, or a combination of polypropylene and polyethylene, because of its light weight, chemical resistance, and excellent thermal adhesiveness.
[0031] As described later, mesenchymal stem cells are adhered to the carrier 40 and float. For this reason, the filter 30 preferably has a mesh size that is not penetrated by the carrier 40 and allows the non-adhered mesenchymal stem cells to penetrate. Live mesenchymal stem cells remain adhered to the carrier 40, but dead stem cells detach from the carrier 40, or mesenchymal stem cells that have detached from the carrier 40 die. Since the carrier 40 is generally 200 μm or larger in size and the dead mesenchymal stem cells are around 20 μm in size, for example, the mesh size of the filter 30 is preferably 70 mesh (mesh size of about 185 μm) to 400 mesh (mesh size of about 35 μm).
[0032] <Carrier> FIG. 2(B) is a perspective view showing an example of the carrier 40 used in this embodiment. This embodiment employs a culture method in which stem cells attached to a carrier are grown in a state suspended in a culture solution. To ensure a large culture area and culture capacity and perform mass culture, it is preferable to use a carrier for suspension culture. The carrier may be porous and spherical, polygonal, or disk-shaped. In general, the size of a porous spherical carrier is 140 μm to 280 μm. In this embodiment, for mass culture, a disk-shaped nonwoven carrier 40 with a thickness LT of 200 μm to 500 μm and a diameter ΦDU of Φ3 mm to 9 mm is adopted. It is preferable that the nonwoven fabric has a porous property. The fibers constituting the nonwoven fabric are preferably fibers with a small fiber diameter, and the average fiber diameter is preferably 10 to 100 μm, and particularly preferably 15 to 50 μm.
[0033] The material of the carrier may be an organic material, an inorganic material, or a composite material thereof. Examples of organic materials include synthetic polymers such as polystyrene, polyester, polyurethane, polyethylene, polypropylene, acrylic polymers, acrylamide polymers, polyvinyl alcohol, silicone polymers, and epoxy resins; natural polymers such as collagen and gelatin; polygalacturonic acids such as pectin and pectinate; polysaccharides such as alginate, cellulose, cross-linked agarose, dextran, and chitosan; and examples of inorganic materials include glass and ceramics.
[0034] The amount of carriers to be placed in the culture tank 10 is preferably 5 g to 40 g (dry state) per 1000 ml of culture solution. If the amount of carriers is less than 5 g, the number of mesenchymal stem cells to be cultured is reduced, and the amount of kitesin and the like in the collected supernatant is reduced. On the other hand, if the amount of carriers is more than 40 g, it becomes difficult to control the culture conditions, and the mesenchymal stem cells are more likely to die.
[0035] <Culture method> Fig. 3 is a flow chart showing a method for producing a supernatant liquid. A filter 30 is attached using an attachment string 35 in the culture tank 10 of the culture vessel 100 shown in Fig. 1. Figs. 4(A) and (B) are conceptual diagrams showing the filter 30 attached to a filter holding frame 28. A culture solution discharge nozzle 24 is arranged on the outside of the filter 30. In order to make the carrier 30 easier to see, the various sensors 18, gas supply tube 19, etc. shown in Fig. 1 are not drawn.
[0036] Mesenchymal stem cells, carriers 40 washed with EDTA solution or the like, and FBS-DMEM warmed to 36-38°C are placed in the culture tank 10 (step S31). The mesenchymal stem cells are stem cells that have been frozen and cultured in a flask until they reach the amount required for the culture tank 10. Various sensors 18 measure the temperature, pH, and oxygen concentration as appropriate, and the temperature, pH, and oxygen concentration of the FBS-DMEM are adjusted by a control program.
[0037] Next, the mesenchymal stem cells are attached to the carriers 40 (step S32). The stirring paddle 12 stirs the FBS-DMEM at a predetermined rotation speed so that the mesenchymal stem cells are attached to the carriers 40, and the carriers 40 are suspended in the FBS-DMEM. Furthermore, the rotation of the stirring paddle 12 is stopped to settle the FBS-DMEM in the culture tank 10 so that the mesenchymal stem cells are reliably attached to the carriers 40. The first period for stirring the FBS-DMEM is, for example, 1 minute to 59 minutes per hour, while the second period for stopping the stirring is 59 minutes to 1 minute. This stirring and stopping of the stirring is continued for 48 hours to 72 hours. The rotation of the stirring paddle 12 may be constant or variable.
[0038] Next, mesenchymal stem cells are cultured (step S33). The stirring paddle 12 stirs the FBS-DMEM at a predetermined rotation speed so that the carrier 40 floats in the FBS-DMEM. This allows the mesenchymal stem cells to grow three-dimensionally on the carrier 40. When the mesenchymal stem cells grow and the weight of the carrier 40 becomes heavy, the carrier 40 will not float in the FBS-DMEM unless the rotation speed of the stirring paddle 12 is increased. For this reason, it is preferable to gradually increase the rotation speed of the stirring paddle 12. When the mesenchymal stem cells occupy all the areas of the carrier 40, the plateau phase (stationary phase) is entered. For this reason, the carrier 40 floats in the FBS-DMEM even if the rotation speed of the stirring paddle 12 is kept constant. When the plateau phase is reached, the culture is completed, and the culture time is 72 to 96 hours. FIG. 4(A) is a diagram showing the carrier 40 floating in the FBS-DMEM.
[0039] Next, the culture solution discharge nozzle 24 removes the FBS-DMEM (step S34). At this time, the stirring paddle 12 is stopped. As the culture solution discharge nozzle 24 discharges the FBS-DMEM, the carrier 40 gets caught in the filter 30. Figure 4(B) is a diagram showing the state in which the FBS-DMEM has been almost completely removed and the carrier 40 is caught in the filter 30.
[0040] Next, phosphate-buffered saline (PBS) is supplied to the culture tank 10, and the stirring paddle 12 rotates at high speed for several to 10 minutes. This cleans the entire culture tank 10, including the filter 30, the carrier 40, the various sensors 18, the gas supply tube 19, etc. (step S35). Then, the culture solution discharge nozzle 24 collects the phosphate buffer, and the collected phosphate buffer is removed.
[0041] Next, CM-DMEM warmed to 36-38° C. is introduced into the culture tank 10 (step S36). Various sensors 18 measure the temperature, pH, and oxygen concentration as appropriate, and the temperature, pH, and oxygen concentration of the CM-DMEM are adjusted by a control program.
[0042] Next, the mesenchymal stem cells are cultured (step S37). The stirring paddle 12 stirs the CM-DMEM at a predetermined rotation speed so that the carriers 40 are suspended in the CM-DMEM. This allows the mesenchymal stem cells to be cultured on the carriers 40. The culture time is 40 to 60 hours.
[0043] Next, the CM-DMEM is collected by the culture solution discharge nozzle 24 (step S38). At this time, the stirring paddle 12 is stopped. The culture solution discharge nozzle 24 collects the CM-DMEM, which is stored as a culture supernatant of mesenchymal stem cells.
[0044] The collected CM-DMEM (culture supernatant) is then judged as to whether the state of the mesenchymal stem cells is good (step S39). Whether the state of the mesenchymal stem cells is good may be judged, for example, by whether at least one of the measured cytokines and exosomes is greater than a predetermined threshold. If at least one of the secreted cytokines and exosomes is greater than a predetermined value, this indicates that the state of the mesenchymal stem cells is good.
[0045] When the state of the mesenchymal stem cells is good, steps S36 - S38 are continuously repeated. When the state of the mesenchymal stem cells is bad, the process proceeds to step S40, and FBS - DMEM warmed to 36 - 38°C is introduced into the culture tank 10. Then the process proceeds to steps S33 - S34. That is, nutrients in the form of serum are provided to the mesenchymal stem cells, and the mesenchymal stem cells proliferate or return to a good state.
[0046] In step S39, whether the state of the mesenchymal stem cells is good or not is determined by whether cytokines, etc. are more than a predetermined threshold, but it is not necessarily necessary to measure every time. If the culture with FBS - DMEM and the culture with CM - DMEM are alternately repeated, and it is known that the secreted cytokines, etc. are more than a predetermined threshold, then the culture with FBS - DMEM and the culture with CM - DMEM can be alternately repeated without measuring every time. Even if the culture with CM - DMEM is continuously performed 4 times and then the culture with FBS - DMEM is performed once, if it is known that the secreted cytokines, etc. are more than a predetermined threshold, a cycle of 4 consecutive cultures with CM - DMEM and 1 culture with FBS - DMEM may also be used.
Example
[0047] <Culture of immortalized human dental pulp stem cells> As human dental pulp stem cells, human deciduous dental pulp stem cells (SHED) prepared from the dental pulp tissue of human deciduous teeth were used. Also, this SHED was immortalized by introducing the SV40 gene using a viral vector. This immortalized SHED (hereinafter referred to as IM - SHED) was stored in a freezer at - 80°C, thawed at room temperature, and cultured in a flask with FBS - DMEM at 37°C. After repeating sub - culturing, when 32 flasks became fully confluent, they were placed in the culture tank 10.
[0048] <Culture of IM - SHED with FBS - DMEM> IM-SHED, 60 g (dry weight) of a disk-shaped nonwoven fabric carrier 40, and 4000 ml of FBS-DMEM were placed in a 10 liter culture tank 10. The mesh size of the filter 30 was 180 mesh (mesh size of approximately 84 μm). The FBS-DMEM was prepared at pH 7.0, dissolved oxygen 2.0, and temperature 37°C.
[0049] The IM-SHED, nonwoven fabric carrier 40, and FBS-DMEM were stirred by the stirring paddle 12. The stirring paddle 12 was programmed to rotate at 20-40 rpm for a predetermined time, then stop rotating and rotate again for a predetermined time so that the IM-SHED would adhere to the carrier 40. After 24 hours, 1000 ml of FBS-DMEM was added to the culture tank 10.
[0050] After the process of adhering IM-SHED to the carrier 40 was performed for 48 to 72 hours, the stirring paddle 12 was used to stir the FBS-DMEM at a rotation speed of 40 rpm so that the carrier 40 was suspended in the FBS-DMEM. As the IM-SHED attached to the carrier 40 proliferated over time, the carrier 40 became less likely to float in the FBS-DMEM. For this reason, the stirring paddle 12 was gradually increased in rotation speed from 40 rpm to 70 rpm to stir the FBS-DMEM.
[0051] 216 hours after the introduction of the IM-SHED, carrier 40, and FBS-DMEM, the cultivation of the IM-SHED was completed, and the FBS-DMEM was collected by the culture solution discharge nozzle 24. Then, 5000 ml of phosphate buffer solution was supplied to the culture tank 10, and the entire culture tank 10 including the filter 30, carrier 40, etc. was washed.
[0052] Next, 7500 ml of CM-DMEM warmed to 37°C was poured into the culture tank 10, and IM-SHED was cultured. The stirring paddle 12 stirred the CM-DMEM at a rotation speed of 50 rpm to 60 rpm so that the carriers 40 were suspended in the CM-DMEM. The culture time of IM-SHED was 48 hours.
[0053] Next, the CM-DMEM was collected using the culture medium discharge nozzle 24 and stored in a refrigerator or freezer as the culture supernatant of the IM-SHED.
[0054] As shown in Table 1, the collected culture supernatant contains high concentrations of cytokines, such as VEGF at 3711.5 pg / ml and HGF at 2566.7 pg / ml. For example, the threshold for VEGF was set at 3400 pg / ml, and the threshold for HGF at 2300 pg / ml. For this reason, CM-DMEM was added to the culture tank 10 without adding FBS-DMEM, and the culture supernatant was continuously collected. In other words, steps S36-S38 in FIG. 3 were continuously repeated. [Table 1]
[0055] In Table 1, IM-SHED-AUTO (automated culture of immortalized human dental pulp stem cells) is the concentration of cytokines in this example, IM-SHED (immortalized human dental pulp stem cells) is the concentration when an operator uses a flask, and SHED (non-immortalized human dental pulp stem cells) is the concentration when an operator uses a flask.
[0056] It was confirmed that when CM-DMEM was continuously added to the culture tank 10 five times without adding FBS-DMEM, the VEGF concentration fell below the threshold value. In order to ensure that the threshold value was exceeded, in the embodiment, the culture supernatant was automatically collected in a cycle in which CM-DMEM was continuously added two times and FBS-DMEM was added once. As a result, even after 40 cycles (80 additions of CM-DMEM and 40 additions of FBS-DMEM) were repeated over a nine-month period, a culture supernatant containing a high concentration of cytokines as shown in Table 1 could be obtained.
[0057] In this embodiment, not only can a high concentration of cytokines be obtained, but also a large amount of culture supernatant can be obtained. For example, when IM-SHED is cultured using flasks, 30 ml of culture supernatant can be obtained from one flask. The amount of culture that can be cultured by two workers using flasks is about 100 at most, and 24 L of culture supernatant can be obtained per month. On the other hand, in this embodiment, 80 L of culture supernatant can be obtained automatically per month with almost no intervention by the workers. If the capacity of the culture tank 10 is 20 L, it is possible to obtain 160 L of culture supernatant. [Explanation of symbols]
[0058] 10 ... culture tank, 12 ... stirring paddle, 13 ... stirring shaft 15 ... bearing, 16 ... rotating motor, 18 ... various sensors 19 ... gas supply tube, 22 ... top plate, 24 ... culture medium discharge nozzle 25 … Heater, 28 … Filter holder 30 ... filter, 31 ... opening, 33 ... bottom 40 ... carrier, 100 ... culture vessel
Claims
1. A method for producing a culture supernatant obtained by removing mesenchymal stem cells from a culture medium in which mesenchymal stem cells have been cultured, comprising the steps of: (a) supplying a culture medium (hereinafter, FBS-DMEM) containing a carrier, the mesenchymal stem cells, and serum to a culture vessel; (b) after the step (a), adhering the mesenchymal stem cells to the carrier; (c) culturing the mesenchymal stem cells using the FBS-DMEM; (d) removing the FBS-DMEM while leaving the mesenchymal stem cells attached to the carrier in the filter; (e) after the step (c), washing the culture vessel, the mesenchymal stem cells attached to the carrier, and the filter; (f) supplying a serum-free culture medium for supernatant (hereinafter, CM-DMEM) to the culture tank after the (d) step; (g) culturing the mesenchymal stem cells using the CM-DMEM; (h) leaving the mesenchymal stem cells adhered to the carrier in the filter and recovering the CM-DMEM; A method for producing a culture supernatant comprising the steps of:
2. 2. The method for producing a culture supernatant according to claim 1, wherein the step (b) comprises a first period during which the FBS-DMEM is stirred so that the carriers are suspended in the FBS-DMEM, and a second period during which stirring is stopped.
3. The method for producing a culture supernatant according to claim 1, wherein in the step (c), the FBS-DMEM is stirred so that the carriers are suspended in the FBS-DMEM.
4. 2. The method for producing a culture supernatant according to claim 1, wherein in the step (g), the CM-DMEM is stirred so that the carrier is suspended in the CM-DMEM.
5. The method for producing a culture supernatant according to any one of claims 1 to 4, wherein the mesh size of the filter is from 70 mesh to 400 mesh.
6. The method for producing a culture supernatant according to claim 1 , wherein after the steps (a) to (e), the steps (f), (g) and (h) are successively repeated.
7. The method for producing a culture supernatant according to claim 6 , wherein the steps (f), (g) and (h) are repeated two to four times in succession.
8. When at least one of cytokines and exosomes is less than a predetermined value in the recovered CM-DMEM, the steps (c) and (e) are carried out only once; The method for producing a culture supernatant according to any one of claims 1 to 4, wherein when at least one of cytokines and exosomes is greater than a predetermined value in the recovered CM-DMEM, steps (f), (g) and (h) are continuously repeated.
9. The method for producing a culture supernatant according to any one of claims 1 to 4, wherein the mesenchymal stem cells are immortalized stem cells.
10. The method for producing a culture supernatant according to claim 9 , wherein the immortalized stem cells are deciduous dental pulp stem cells.
11. A method for producing a culture supernatant obtained by removing mesenchymal stem cells from a culture medium in which mesenchymal stem cells have been cultured, comprising the steps of: (p) culturing the mesenchymal stem cells adhered to the carrier in a culture vessel using a serum-containing culture medium (hereinafter, FBS-DMEM), and then leaving the mesenchymal stem cells adhered to the carrier in a filter placed in the culture vessel and removing the FBS-DMEM; (q) after the step (p), washing the culture vessel, the mesenchymal stem cells attached to the carrier, and the filter; (r) after the step (q), supplying a serum-free culture medium for supernatant (hereinafter, referred to as CM-DMEM) to the culture vessel, culturing the mesenchymal stem cells using the CM-DMEM, and then recovering the CM-DMEM while leaving the mesenchymal stem cells adhered to the carrier in the filter; A method for producing a culture supernatant comprising the steps of:
12. The method for producing a culture supernatant according to claim 11, wherein the steps (p) and (q) are carried out once, then the step (r) is repeated two to four times in succession, and again the steps (p) and (q) are carried out once, then the step (r) is repeated two to four times in succession.
13. The method for producing a culture supernatant according to claim 11 or 12, wherein the capacity of the culture tank is from 5 L to 20 L, and the mesh size of the filter is from 70 mesh to 400 mesh.
14. The method for producing a culture supernatant according to claim 11 or 12, wherein the mesenchymal stem cells are immortalized stem cells.
Citation Information
Patent Citations
Method for preparing exosomes of mesenchymal stem cells
CN110669729A
Novel high-density microcarrier interception device for perfusion culture and use method
CN114058505A
Apparatus for culturing cell of living body
JP1995203945A
Method and device for culturing biological cell
JP2011092117A
Apparatus and methods for statically culturing adherent cell
JP2021065186A
Cited By
Bfgf production method
WO2025159096A1
